kalshi Science and Technology

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027?

Before Mar 1, 2027
Closes Mar 01, 2027 (225d) 24h volume 74 Open interest 845 Event When will the FDA approve Compass Pathways' COMP360 Psilocybin?
56%
implied YES probability

Price history

Last 10 days · High 78% · Low 42% · 7d +40.5pp
78%42%

Other outcomes in this event

Related stocks

Trade on Kalshi

Open on Kalshi
Frenzy Capital does not execute trades on prediction markets — we aggregate public order-book and trading data for analysis.

Prediction market data reflects speculative event probabilities, not guaranteed outcomes. This is not investment advice. See Terms §17.